Oral paclitaxel, Carboplatin, and Dostarlimab (OPE/Cb/D) without and with Trastuzumab in early-stage, high-risk breast cancer: Results from the neoadjuvant I-SPY 2 TRIAL.
Carboplatin;Dostarlimab;Paclitaxel;Trastuzumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Oral paclitaxel, Carboplatin, and Dostarlimab (OPE/Cb/D) without and with Trastuzumab in early-stage, high-risk breast cancer: Results from the neoadjuvant I-SPY 2 TRIAL. ### Output: Carboplatin;Dostarlimab;Paclitaxel;Trastuzumab